6-chloro-3-[(1R)-1-[[5-(3-cyclopropylimidazol-4-yl)-1,3-thiazol-2-yl]amino]ethyl]-1H-quinolin-2-one
C20H18ClN5OS — CID 122637390
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-chloro-3-[(1R)-1-[[5-(3-cyclopropylimidazol-4-yl)-1,3-thiazol-2-yl]amino]ethyl]-1H-quinolin-2-one
6-chloro-3-[(1R)-1-[[5-(3-cyclopropylimidazol-4-yl)-1,3-thiazol-2-yl]amino]ethyl]-1H-quinolin-2-one (PubChem CID 122637390) has the molecular formula C20H18ClN5OS and a molecular weight of 411.92 g/mol. Its IUPAC name is 6-chloro-3-[(1R)-1-[[5-(3-cyclopropylimidazol-4-yl)-1,3-thiazol-2-yl]amino]ethyl]-1H-quinolin-2-one.
Molecular Properties
| Compound Name | 6-chloro-3-[(1R)-1-[[5-(3-cyclopropylimidazol-4-yl)-1,3-thiazol-2-yl]amino]ethyl]-1H-quinolin-2-one |
|---|---|
| PubChem CID | 122637390 |
| Molecular Formula | C20H18ClN5OS |
| Molecular Weight | 411.92 g/mol |
| Exact Mass | 411.09 |
| IUPAC Name | 6-chloro-3-[(1R)-1-[[5-(3-cyclopropylimidazol-4-yl)-1,3-thiazol-2-yl]amino]ethyl]-1H-quinolin-2-one |
| SMILES | C[C@@H](Nc1ncc(-c2cncn2C2CC2)s1)c1cc2cc(Cl)ccc2[nH]c1=O |
| InChI | InChI=1S/C20H18ClN5OS/c1-11(15-7-12-6-13(21)2-5-16(12)25-19(15)27)24-20-23-9-18(28-20)17-8-22-10-26(17)14-3-4-14/h2,5-11,14H,3-4H2,1H3,(H,23,24)(H,25,27)/t11-/m1/s1 |
| InChIKey | CSPYEYXNCHCWCF-LLVKDONJSA-N |
| XLogP | 5.01 |
| TPSA | 75.60 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 411.92 |
| LogP ≤ 5 | 5.01 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122637390 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.